CompanyGraph
At a glance
- Depends onMidstream position: 6 outgoing, 8 incoming connections
- ScaleMarket cap is $4.21B, above the global median of $1.15B
- FinancialsAltman Z-Score 1.63: grey zone
Sign in to view price data.
Sign inThe reported statements, read against the company's own industry.
Financials view
Market Capitalization
4.21BUSDvs all stocks (USD)
Trailing P/E
22.60xvs Medical Devices peers
Revenue (TTM)
1.47BUSDvs all stocks (USD)
Profit Margin
12.81%vs Medical Devices peers
Beta
0.8690xvs all stocks
52-Week Change
46.44%vs all stocks
Market Capitalization
4.21BUSDvs all stocks (USD)
Enterprise Value
4.06BUSDvs all stocks (USD)
Trailing P/E
22.60xvs Medical Devices peers
Forward P/E
16.39xvs Medical Devices peers
PEG Ratio
0.0764xvs Medical Devices peers
Price to Sales (TTM)
2.86xvs Medical Devices peers
Price to Book (MRQ)
3.18xvs Medical Devices peers
Enterprise to Revenue
2.76xvs Medical Devices peers
Enterprise to EBITDA
15.60xvs Medical Devices peers
Gross Margin
70.07%vs Medical Devices peers
Profit Margin
12.81%vs Medical Devices peers
Operating Margin
13.54%vs Medical Devices peers
Return on Assets (TTM)
5.04%vs Medical Devices peers
Return on Equity (TTM)
15.40%vs Medical Devices peers
Revenue (TTM)
1.47BUSDvs all stocks (USD)
Revenue per Share (TTM)
26.89USDUpdated Sep 27, 2026Quarterly Revenue Growth
10.80%vs Medical Devices peers
Gross Profit (TTM)
996.85MUSDvs all stocks (USD)
EBITDA (TTM)
267.77MUSDvs all stocks (USD)
Net Income (TTM)
188.55MUSDvs all stocks (USD)
Quarterly Earnings Growth (YoY)
299.70%vs Medical Devices peers
Operating Cash Flow (TTM)
249.26MUSDvs all stocks (USD)
Levered Free Cash Flow (TTM)
59.87MUSDvs all stocks (USD)
Trailing Annual Dividend Rate
0.00USDUpdated Sep 27, 2026Trailing Annual Dividend Yield
0.00%vs all stocks
Payout Ratio
0.00%vs Medical Devices peers
Revenue
1.39BUSDFY2025 · Dec 31, 2025Cost of Goods Sold
448.18MUSDFY2025 · Dec 31, 2025Gross Profit
939.87MUSDFY2025 · Dec 31, 2025Operating Income
199.39MUSDvs all stocks (USD)
Pre-tax Income
-220.78MUSDFY2025 · Dec 31, 2025Income Tax Expense
21.64MUSDFY2025 · Dec 31, 2025Net Income
-242.47MUSDFY2025 · Dec 31, 2025EBIT
-171.50MUSDFY2025 · Dec 31, 2025EBITDA (Income Statement)
278.67MUSDFY2025 · Dec 31, 2025Research & Development
185.76MUSDFY2025 · Dec 31, 2025Selling, General & Administrative
548.81MUSDFY2025 · Dec 31, 2025Other Operating Expenses
5.90MUSDFY2025 · Dec 31, 2025Non-operating Interest Income
18.98MUSDFY2025 · Dec 31, 2025Non-operating Interest Expense
49.29MUSDFY2025 · Dec 31, 2025EPS (Basic)
-4.45USDFY2025 · Dec 31, 2025EPS (Diluted)
-4.45USDFY2025 · Dec 31, 2025Basic Shares Outstanding
54.50MSharesFY2025 · Dec 31, 2025Diluted Shares Outstanding
54.50MSharesFY2025 · Dec 31, 2025Net Income from Continuing Operations
-242.47MUSDFY2025 · Dec 31, 2025Operating Cash Flow
261.57MUSDFY2025 · Dec 31, 2025Free Cash Flow
180.52MUSDFY2025 · Dec 31, 2025Cash & Cash Equivalents (End of Period)
635.55MUSDFY2025 · Dec 31, 2025Income Tax Paid
29.37MUSDFY2025 · Dec 31, 2025Interest Paid
31.07MUSDFY2025 · Dec 31, 2025Starting Profit (CF Statement)
-242.47MUSDFY2025 · Dec 31, 2025Depreciation & Amortization
59.63MUSDFY2025 · Dec 31, 2025Deferred Taxes (CF)
455.00KUSDFY2025 · Dec 31, 2025Stock-based Compensation
36.29MUSDFY2025 · Dec 31, 2025Other Non-cash Items
34.10MUSDFY2025 · Dec 31, 2025Change in Accounts Receivable (CF)
-10.71MUSDFY2025 · Dec 31, 2025Change in Accounts Payable (CF)
-13.45MUSDFY2025 · Dec 31, 2025Change in Other Assets/Liabilities
397.71MUSDFY2025 · Dec 31, 2025Capital Expenditures
-81.05MUSDFY2025 · Dec 31, 2025Purchase of Investments
-5.67MUSDFY2025 · Dec 31, 2025Sale of Investments
6.52MUSDFY2025 · Dec 31, 2025Other Investing Activity
7.28MUSDFY2025 · Dec 31, 2025Net Investing Cash Flow
-72.91MUSDFY2025 · Dec 31, 2025Long-term Debt Issuance
0.00USDFY2025 · Dec 31, 2025Long-term Debt Payments
-280.93MUSDFY2025 · Dec 31, 2025Other Financing Charges
-338.00KUSDFY2025 · Dec 31, 2025Net Financing Cash Flow
-281.26MUSDFY2025 · Dec 31, 2025Shares Outstanding
55.05MSharesUpdated Sep 27, 2026Float Shares
54.84MSharesUpdated Sep 27, 2026Shares Short
5.38MSharesUpdated Sep 27, 2026Short Ratio
9.52daysvs all stocks
Short % of Shares Outstanding
11.20%vs all stocks
% Held by Insiders
0.41%vs all stocks
% Held by Institutions
113.07%vs all stocks
Total Cash (MRQ)
516.62MUSDvs all stocks (USD)
Total Cash per Share (MRQ)
9.38USDUpdated Sep 27, 2026Total Debt (MRQ)
351.95MUSDvs all stocks (USD)
Total Debt to Equity (MRQ)
0.2656xvs Medical Devices peers
Current Ratio (MRQ)
1.45xvs Medical Devices peers
Book Value per Share (MRQ)
24.07USDUpdated Sep 27, 2026Total Assets
2.61BUSDvs all stocks (USD)
Total Current Assets
1.10BUSDFY2025 · Dec 31, 2025Total Liabilities
1.41BUSDFY2025 · Dec 31, 2025Total Non-current Assets
1.50BUSDFY2025 · Dec 31, 2025Total Non-current Liabilities
597.99MUSDFY2025 · Dec 31, 2025Total Current Liabilities
808.07MUSDFY2025 · Dec 31, 2025Cash & Cash Equivalents
635.55MUSDFY2025 · Dec 31, 2025Accounts Receivable
215.99MUSDFY2025 · Dec 31, 2025Inventory
164.70MUSDFY2025 · Dec 31, 2025Accounts Payable
97.16MUSDFY2025 · Dec 31, 2025Short-term Debt
40.26MUSDFY2025 · Dec 31, 2025Deferred Revenue
11.51MUSDFY2025 · Dec 31, 2025Other Current Liabilities
446.37MUSDFY2025 · Dec 31, 2025Long-term Debt
393.51MUSDFY2025 · Dec 31, 2025Other Non-current Liabilities
97.41MUSDFY2025 · Dec 31, 2025Common Stock (Book)
84.56MUSDFY2025 · Dec 31, 2025Retained Earnings
-1.15BUSDFY2025 · Dec 31, 2025Total Shareholders' Equity
1.20BUSDvs all stocks (USD)
Treasury Stock
1.17MUSDFY2025 · Dec 31, 202552-Week Low
48.82USDUpdated Sep 27, 202652-Week High
85.76USDUpdated Sep 27, 202652-Week Change
46.44%vs all stocks
Beta
0.8690xvs all stocks
50-Day MA
79.54USDUpdated Sep 27, 2026200-Day MA
71.03USDUpdated Sep 27, 2026Avg 10-Day Volume
735.21KSharesUpdated Sep 27, 2026Avg 30-Day Volume
621.02KSharesUpdated Sep 27, 2026Diluted EPS (TTM)
3.39USDUpdated Sep 27, 2026Other Income / Expense
-389.87MUSDFY2025 · Dec 31, 2025Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Financial Health
Altman Z-Score 1.63: grey zoneSignificant
Altman Z-Score: 1.63
Supply Chain
Midstream position: 6 outgoing, 8 incoming connectionsNotable
Outgoing: 6.00Incoming: 8.00
High connectivity hub: 14 industry connectionsNotable
Total Connections: 14.00
Scale
Market cap is $4.21B, above the global median of $1.15BNotable
Market cap (USD): 4,209,557,016Global Median: 1,147,475,461.207
Revenue is $1.47B, above the global median of $560.16MNotable
Revenue (USD): 1,471,518,976Global Median: 560,158,223.094
Levered free cash flow is $59.87M, above the global median of $18.74MNotable
Levered free cash flow (USD): 59,872,624Global Median: 18,742,325.209
Companies that share the same coordination system — how they create, deliver, or capture value.
Tango Therapeutics Inc.
Tier 1ProductionApproval-Gated PipelineRuleRisk
Indivior Pharmaceuticals, Inc.
Tier 1ProductionApproval-Gated PipelineRule
Changchun High-Tech Industry Co. Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Xuanzhu Biopharmaceutical Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Edgewise Therapeutics, Inc.
Tier 1ProductionApproval-Gated PipelineRuleRisk
China Medical System Holdings Limited
Tier 1ProductionApproval-Gated PipelineRule
Integer Holdings Corporation
Tier 1ProductionApproval-Gated PipelineRule
Suzhou Zelgen Biopharmaceuticals Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRuleRisk
Viking Therapeutics Inc.
Tier 1ProductionApproval-Gated PipelineRule
Ajanta Pharma Ltd.
Tier 1ProductionApproval-Gated PipelineRule